
Master Thesis in Epigenetic Cancer Research - Department of Medicine 2, Hematology and Oncology
Drucken
Frankfurt am Main
Informationen zur Anzeige:
Master Thesis in Epigenetic Cancer Research - Department of Medicine 2, Hematology and Oncology
Frankfurt am Main
Aktualität: 11.06.2025
Anzeigeninhalt:
11.06.2025, Universitätsklinikum Frankfurt
Frankfurt am Main
Master Thesis in Epigenetic Cancer Research - Department of Medicine 2, Hematology and Oncology
Aufgaben:
The project focuses on deciphering a novel cancer vulnerability in Lymphoma. The gene of interest is involved in ubiquitin and epigenetic signaling, which appear to influence B-cell development.
Molecular biology tasks include Western Blotting, cell culture, DNA-damage and replication assays, flow cytometry and image-based assays.
Genetic modification of cancer cell lines utilizing CRISPR-Cas9 and shRNA-mediated knockdowns
State-of-the-Art advanced techniques such as proximity-labeling, MassSpec proteomics, RNAseq, and CHIP-seq
Data analysis, figure generation and scientific presentations
Bioinformatic analysis in R including exploratory data analysis, gene set enrichment analysis and figure generation utilizing ggplot and Bioconductor packages (optional)
Code documentation with version control using GitHub (optional)
Qualifikationen:
Enrolled in a university master program in biology, biochemistry or a related discipline Enthusiasm and fascination for biomedical research, oncology, cell and molecular biology High motivation for experimental lab work Experiences in cell and molecular biological as well as biochemical lab techniques might be of advantage Experiences in coding languages such as R and Python are beneficial Ability to work in a team, sense of responsibility and proactivity Basic knowledge in MS Office (Word, Excel) Due to legal regulations, valid proof of measles immunity / measles vaccination is required
Standorte